(Q34130056)

English

Antibiotic resistance

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

Antibiotic resistance. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

antibiotic resistance

1 reference

based on heuristic

inferred from title

author name string

Cunha BA

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 November 2000

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Medical Clinics of North America

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

84

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1407-1429

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Broad- and narrow-spectrum antibiotics: an unhelpful categorization

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Consequences of bacterial resistance to antibiotics in medical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Trends in bacterial resistance to fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Antimicrobial Resistance in Streptococcus pneumoniae: An Overview

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

United States geographic bacteria susceptibility patterns. 1997 ASCP Susceptibility Testing Group

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Bacterial resistance to antimicrobial agents: selected problems in France, 1996 to 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in North America

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

From Micrococcus to Moraxella. The reemergence of Branhamella catarrhalis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. The Spanish Pseudomonas aeruginosa Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Emergence of drug-resistant pneumococcal infections in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Molecular epidemiologic analysis of multiresistant Klebsiella pneumoniae isolates from a pediatric hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Antibiotic resistance. Control strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Penicillin-resistant pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Doxycycline re-revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Antibiotic resistance: a historical perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

An antibiotic policy to prevent emergence of resistant bacilli.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Strategies for selecting antibiotics in intensive care units.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Vancomycin-resistant Enterococcus faecium in a Veterans Affairs Medical Center: association with antibiotic usage

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997)

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Selection of fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus with ciprofloxacin and trovafloxacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Antimicrobial resistance among Haemophilus influenzae isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Enterococci and vancomycin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Determinants of vancomycin use in adult intensive care units in 41 United States hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Impact of use of multiple antimicrobials on changes in susceptibility of gram-negative aerobes

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Variations in antimicrobial use and cost in more than 2,000 patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Quinolone resistance in veterinary isolates of Salmonella.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Practical strategies for the appropriate use of antimicrobials

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Antibiotic use and pneumococcal resistance to penicillin: the French experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

In vitro comparative activity of meropenem with 15 other antimicrobial agents against 1798 Pseudomonas aeruginosa isolates in a French multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Drug-resistant Streptococcus pneumoniae: rational antibiotic choices.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Antimicrobial-resistant pathogens in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Prevalence and resistance mechanisms of common bacterial respiratory pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls: the complexity of the problem

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Management of infections due to antibiotic-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Modification of prescribers' behavior: the Icelandic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Nosocomial infections with ceftazidime-resistant Pseudomonas aeruginosa: risk factors and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Low-level colonization and infection with ciprofloxacin-resistant gram-negative bacilli in a skilled nursing facility.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Changes in intestinal flora of farm personnel after introduction of a tetracycline-supplemented feed on a farm

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Prevention of neural-tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Hospital study of adult community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Doxycycline in respiratory infections: a re-assessment after 17 years

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Inhibition of the emergence of ciprofloxacin resistance in Streptococcus pneumoniae by the multidrug efflux inhibitor reserpine.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Antimicrobial Resistance in Hospital Organisms and Its Relation to Antibiotic Use

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Oropharyngeal Gram-negative bacillary carriage: a survey of 120 healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

René Dubos: a harbinger of microbial resistance to antibiotics.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Imipenem resistance in aerobic gram-negative bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Resistance patterns of Pseudomonas aeruginosa to carbapenems and piperacillin/tazobactam

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Problems with antimicrobial resistance in gram-positive cocci

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Infections caused by erythromycin-resistant Streptococcus pneumoniae: incidence, risk factors, and response to therapy in a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Use of pharmacodynamic indices to predict efficacy of combination therapy in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, data summary from January 1996 through December 1997: A report from the National Nosocomial Infections Surveillance (NNIS) System

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Infections and antibiotic resistance in nursing homes

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Bactericidal effects of levofloxacin in comparison with those of ciprofloxacin and sparfloxacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Decrease of vancomycin-resistant enterococci in poultry meat after avoparcin ban

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Patterns and modes of beta-lactam resistance in Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997).

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: are beta-lactamase inhibitors of therapeutic value?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Antimicrobial resistance in anaerobes

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Fluoroquinolone use and fluoroquinolone resistance: is there an association?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Treatment of severe infections caused by penicillin-resistant pneumococci. Role of third generation cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Susceptibility of penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to newer antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Evolution of resistance among clinical isolates of Acinetobacter over a 6-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Resistant Pneumococcus: a worldwide problem.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Successful treatment of ceftazidime-resistant Klebsiella pneumoniae ventriculitis with intravenous meropenem and intraventricular polymyxin B: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Doxycycline activity against Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Novel mechanism of macrolide resistance in Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

The significance of serum vs tissue levels of antibiotics in the treatment of penicillin-resistant Streptococcus pneumoniae and community-acquired pneumonia: are we looking in the wrong place?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Antibiotic policy: a tool for controlling resistance of hospital pathogens.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Detection of carbapenemase-producing Acinetobacter baumannii in a hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

In vitro activities of oral beta-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Resistance to ciprofloxacin in pathogenic Enterobacteriaceae in England and Wales in 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Resistance to ciprofloxacin in non-typhoidal salmonellas from humans in England and Wales-the current situation

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Ciprofloxacin-resistant Salmonella typhi and treatment failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

New faces of an old pathogen: emergence and spread of multidrug-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Epidemiological analysis of imipenem-resistant Serratia marcescens in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Bacterial resistance to ciprofloxacin in Greece: results from the National Electronic Surveillance System. Greek Network for the Surveillance of Antimicrobial Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Clinical aspects of antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Hemophilus influenzae pneumonia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

An international perspective on antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Managing antibiotic use--impact of infection control

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Vancomycin-resistant Staphylococcus aureus: infection control considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Mechanisms of quinolone resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Outer membrane protein profiles of Xanthomonas maltophilia isolates displaying temperature-dependent susceptibility to gentamicin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Predicting susceptibility of Streptococcus pneumoniae to ceftriaxone and cefotaxime by cefuroxime and ceftizoxime disk diffusion testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Penicillin-nonsusceptible Streptococcus pneumoniae at San Francisco General Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Multicenter study of the in vitro activity of cefepime in comparison with five other broad-spectrum antibiotics against clinical isolates of Gram-positive and Gram-negative bacteria from hospitalized patients in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

Effects of antibiotic therapy on Pseudomonas aeruginosa-induced lung injury in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative in vitro activities of amoxicillin-clavulanate against aerobic and anaerobic bacteria isolated from antral puncture specimens from patients with sinusitis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Aminoglycosides: activity and resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic resistance: the Bermuda experience

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970295-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0025-7125(05)70295-9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34130056&oldid=1976352663"